Recovery Doesn't Always Mean Complete Abstinence—And That's Okay

Recovery from addiction doesn't have to be all-or-nothing. According to recent research from the National Institute on Drug Abuse (NIDA), reducing substance use—rather than achieving complete abstinence—can be a clinically meaningful and valid path to recovery for many people.

What Does "Reduced Use" Actually Mean in Recovery?

The traditional approach to addiction treatment has long focused on complete abstinence as the gold standard. But this high bar may be unrealistic for many people struggling with substance use disorders. "Abstinence is a high bar comparable to requiring that an antidepressant produce complete remission of depression or that an analgesic completely eliminate pain," explains Dr. Nora Volkow from NIDA.

Surprisingly, data from the 2022 National Survey on Drug Use and Health revealed that 65.2% of adults in self-identified recovery used alcohol or other drugs in the past month. This finding challenges the traditional binary view of recovery and suggests that many people consider themselves in recovery despite not maintaining complete abstinence.

Why Are Treatment Goals Shifting Away from All-or-Nothing?

The shift toward accepting reduced use as a valid treatment goal stems from mounting evidence of its real-world benefits. Reducing drug use has clear public health advantages, including fewer overdoses, less infectious disease transmission, and reduced automobile accidents and emergency department visits.

The Food and Drug Administration (FDA) has already embraced this approach for alcohol use disorder, accepting "no heavy drinking days" as a valid outcome measure in medication trials. Heavy drinking is defined as 5 or more drinks per day for men and 4 or more drinks per day for women.

Recent clinical research supports this more flexible approach across different substances:

• Cocaine Treatment: A 2023 analysis of 11 clinical trials found that achieving at least 75% cocaine-negative urine screens was associated with both short- and long-term improvements in psychosocial functioning and addiction severity measures
• Stimulant Disorders: A 2024 analysis of 13 clinical trials showed that reduced stimulant use correlated with improvements in depression severity, craving levels, and various recovery indicators including legal, family, and psychiatric domains
• Cannabis Use: Research on seven clinical trials found that 50% reductions in days of cannabis use and 75% reductions in amount used were associated with meaningful improvements in sleep quality and reduced cannabis use disorder symptoms

How Is Technology Changing Addiction Treatment in 2025?

The landscape of addiction treatment is rapidly evolving with technological advances. Virtual recovery platforms are making treatment more accessible, especially for people in remote areas or those unable to attend in-person sessions. Artificial intelligence is being used to create personalized treatment plans by analyzing patient history, behavior, and health metrics to predict relapse risks and identify triggers.

Wearable technology is also playing an increasingly important role. These devices can track health metrics like heart rate and stress levels, sending alerts when signs of stress or cravings arise and prompting interventions such as mindfulness exercises or quick access to support.

At UC San Diego, Dr. Eric Garland is pioneering Mindfulness-Oriented Recovery Enhancement (MORE), which retrains the brain to rediscover natural rewards lost to addiction. "We found MORE reduced opioid craving by 50% and relapse by 42%," said Dr. Garland. The therapy also cut treatment dropout rates by 59% in clinical trials.

What Are the Benefits of This More Flexible Approach?

Broadening treatment goals beyond complete abstinence could have several important benefits. It may help reduce the stigma typically associated with returning to substance use, which often compounds the sense of failure patients experience when abstinence attempts falter.

Setting abstinence as the only acceptable goal can actually be an obstacle to treatment engagement for those who are unready or unwilling to make that commitment. "Early recovery is pretty painful," explains Nolan Burchett, COO of Touchstone Recovery Center. "Until we want it for ourselves, there's not a very high chance of success."

The approach also recognizes that people in recovery often distinguish between resumption of heavy, compulsive use patterns and isolated returns to substance use. Brief "slips" or "lapses" don't need to be catastrophic to recovery efforts and may even strengthen a person's resolve to recover.

This shift toward more realistic and individualized treatment goals represents a significant evolution in addiction medicine, one that acknowledges the complex, often non-linear nature of recovery while still maintaining focus on meaningful health improvements and harm reduction.